GSK Plugs Into Bioelectronics With $50 Million Venture Fund by Ben Hirschler. Reuters. August 8, 2013.
(1) Bioelectronics or electroceuticals uses _______________ rather than chemicals or biological molecules to treat conditions.
(2) GSK is first investing in SetPoint which is developing a new set of therapies for ___________________.
(3) The bioelectronic approach to these conditions uses an _____________ to stimulate the _____________ to produce an anti-inflammatory effect.
(4) Possible future applications include ________________________________.
Showing posts with label Venture Capital. Show all posts
Showing posts with label Venture Capital. Show all posts
Thursday, August 8, 2013
Thursday, September 27, 2012
Venture Capital Healthcare Firms Ranked
Looking for the Next Big Thing? Ranking the Top 50 Start Ups by Zoran Basich and Emily Maltby. The Wall Street Journal. September 27 2012.
Key Ideas/Summary. The Wall Street Journal ranks annually start-up firms backed by venture capital. The purpose of this ranking is to identify trends and emerging areas. While healthcare firms faded somewhat this year in the ranking, there were several firms of interest: Glaukos Corp, has developed a device to treat glaucoma; NeuroPace Inc. specializes in implantable devices treating neurological disorders; PatientSafe Solutions develops patient-safety systems for hospitals; Achaogen Inc. focuses on antibiotics for multi-drug resistant bacterial infections; Acceleron Pharma Inc. Drugs to treat cancer and rare diseases
Key Ideas/Summary. The Wall Street Journal ranks annually start-up firms backed by venture capital. The purpose of this ranking is to identify trends and emerging areas. While healthcare firms faded somewhat this year in the ranking, there were several firms of interest: Glaukos Corp, has developed a device to treat glaucoma; NeuroPace Inc. specializes in implantable devices treating neurological disorders; PatientSafe Solutions develops patient-safety systems for hospitals; Achaogen Inc. focuses on antibiotics for multi-drug resistant bacterial infections; Acceleron Pharma Inc. Drugs to treat cancer and rare diseases
Subscribe to:
Posts (Atom)